The High Proportion of Painless Thyroiditis as a Cause of Thyrotoxicosis in Korea
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives: The most common cause of thyrotoxicosis is Graves’ disease (GD), while painless thyroiditis (PT) comes in second. In Korea, the treatment of choice for GD is antithyroid drugs (ATDs). Since most cases of PT spontaneously improve, an accurate diagnosis is very important for the proper management of patients presenting with thyrotoxicosis. Materials and Methods: Ninety-nine thyrotoxic patients were routinely checked with 99m Technetium (99mTc) thyroid scan except in pregnant or lactating women. We assessed the patients’ clinical characteristics, serum levels of free T4 (FT4), thyroid stimulating hormone (TSH), thyroid peroxidase antibody (TPOAb), thyroglobulin antibody (TGAb), thyrotropin-binding inhibitory immunoglobulin (TBII), and findings of 99mTc thyroid scan. Results: Among the 99 thyrotoxic patients, 69 were diagnosed with GD and 30 had PT. All of the patients with GD, diagnosed by scan, improved clinically and the thyroid hormone returned to normal with ATDs. All patients with PT improved spontaneously without ATDs. TPOAb and TGAb were positive in 13 (43.3%) and 20 (66.7%) patients with PT, respectively. TPOAb and TGAb were positive in 45 (65.2%) and 44 (63.8%) patients with GD, respectively. TBII was positive in only 73.5% of GD, and was entirely negative in the PT group. Mean FT4 level in GD was higher than in PT, but some patients with PT showed the highest level of FT4. Conclusion: PT accounted for a very high proportion of thyrotoxicosis in this study. All parameters investigated such as age, sex, goiter size or nature, level of FT4, TPOAb or TGAb, and TBII were unable to differentiate GD from PT. Considering the increased proportion of PT in the current study, we recommend routine thyroid scan in all thyrotoxic patients except in pregnant or lactating women.
Abstract
Background and Objectives: The most common cause of thyrotoxicosis is Graves’ disease (GD), while painless thyroiditis (PT) comes in second. In Korea, the treatment of choice for GD is antithyroid drugs (ATDs). Since most cases of PT spontaneously improve, an accurate diagnosis is very important for the proper management of patients presenting with thyrotoxicosis. Materials and Methods: Ninety-nine thyrotoxic patients were routinely checked with 99m Technetium (99mTc) thyroid scan except in pregnant or lactating women. We assessed the patients’ clinical characteristics, serum levels of free T4 (FT4), thyroid stimulating hormone (TSH), thyroid peroxidase antibody (TPOAb), thyroglobulin antibody (TGAb), thyrotropin-binding inhibitory immunoglobulin (TBII), and findings of 99mTc thyroid scan. Results: Among the 99 thyrotoxic patients, 69 were diagnosed with GD and 30 had PT. All of the patients with GD, diagnosed by scan, improved clinically and the thyroid hormone returned to normal with ATDs. All patients with PT improved spontaneously without ATDs. TPOAb and TGAb were positive in 13 (43.3%) and 20 (66.7%) patients with PT, respectively. TPOAb and TGAb were positive in 45 (65.2%) and 44 (63.8%) patients with GD, respectively. TBII was positive in only 73.5% of GD, and was entirely negative in the PT group. Mean FT4 level in GD was higher than in PT, but some patients with PT showed the highest level of FT4. Conclusion: PT accounted for a very high proportion of thyrotoxicosis in this study. All parameters investigated such as age, sex, goiter size or nature, level of FT4, TPOAb or TGAb, and TBII were unable to differentiate GD from PT. Considering the increased proportion of PT in the current study, we recommend routine thyroid scan in all thyrotoxic patients except in pregnant or lactating women.
참고문헌 (25)
- Ponto KA, "Autoimmune thyrotoxicosis: diagnostic challenges", Am J Med, 125(9), pp.S1~ (2012)
- Nikolai TF, "Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism and subacute thyroiditis. Long-term follow-up", Arch Intern Med, 141(11), pp.1455~1458 (1981)
- Pearce EN, "Thyroiditis", N Engl J Med, 348(26), pp.2646~2655 (2003)
- Schorr AB, "Low incidence of painless thyroiditis in the Philadelphia area", Clin Nucl Med, 11(6), pp.379~380 (1986)
- Williams I, "Aetiology of hyperthyroidism in Canada and Wales", J Epidemiol Community Health, 37(3), pp.245~248 (1983)
- Schwartz F, "Incidence rate of symptomatic painless thyroiditis presenting with thyrotoxicosis in Denmark as evaluated by consecutive thyroid scintigraphies", Scand J Clin Lab Invest, 73(3), pp.240~244 (2013)
- Hurley PJ, "A computerized system for rapid evaluation of thyroid function", J Clin Endocrinol Metab, 34(2), pp.354~360 (1972)
- Paunkovic J, "Does autoantibody-negative Graves'disease exist? A second evaluation of the clinical diagnosis", Horm Metab Res, 38(1), pp.53~56 (2006)
- Pedersen IB, "TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays", Clin Endocrinol (Oxf), 55(3), pp.381~390 (2001)
- Schott M, "Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation", Horm Metab Res, 32(10), pp.429~435 (2000)
- Laurberg P, "Environmental iodine intake affects the type of nonmalignant thyroid disease", Thyroid, 11(5), pp.457~469 (2001)
- Costagliola S, "Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease", J Clin Endocrinol Metab, 84(1), pp.90~97 (1999)
- Morita T, "The occurrence of thyrotropin binding-inhibiting immunoglobulins and thyroid-stimulating antibodies in patients with silent thyroiditis", J Clin Endocrinol Metab, 71(4), pp.1051~1055 (1990)
- Kamijo K, "TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor", Endocr J, 50(1), pp.113~116 (2003)
- Iitaka M, "Stimulation of thyroid-stimulating hormone (TSH) receptor antibody production following painless thyroiditis", Clin Endocrinol (Oxf), 60(1), pp.49~53 (2004)
- 이상민, "갑상선중독증에서 그레이브스병과 무통성 갑상선염 감별을 위한 총 T3", 유리 T4 비의 유용성, 2012, pp.27(2), 121~125[DOI]
- Amino N, "Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves'disease and destruction-induced thyrotoxicosis", J Clin Endocrinol Metab, 53(1), pp.113~116 (1981)
- Shigemasa C, "Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels", J Clin Endocrinol Metab, 65(2), pp.359~363 (1987)
- Atkins HL, "Measurement of thyroidal technetium uptake with the gamma camera and computer system", Am J Roentgenol Radium Ther Nucl Med, 118(4), pp.831~835 (1973)
- Hays MT, "Simultaneous measurement of thyroidal trapping (99mTcO4-) and binding (131I-): clinical and experimental studies in man", J Nucl Med, 14(11), pp.785~792 (1973)
- Schneider PB, "Simple, rapid thyroid function testing with 99mTc-pertechnetate thyroid uptake ratio and neck", thigh ratio, 1979, pp.132(2), 249~253
- Higgins HP, "20-Min 99mTc thyroid uptake: a simplified method using the gamma camera", J Nucl Med, 14(12), pp.907~911 (1973)
- Sucupira MS, "The role of 99mTc pertechnetate uptake in the evaluation of thyroid function", Int J Nucl Med Biol, 10(1), pp.29~33 (1983)
- Cho BY, "Clinical thyroidology", pp.305~375 (2010), Medical Book Publishing Company
- Hollowell JG, "Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994):National Health and Nutrition Examination Survey (NHANES III)", J Clin Endocrinol Metab, 87(2), pp.489~499 (2002)